Eli Lilly and Co (LLY)
864.90
+27.33
(+3.26%)
USD |
NYSE |
Mar 24, 16:00
866.90
+2.00
(+0.23%)
After-Hours: 20:00
Eli Lilly Shareholders Equity (Quarterly): 14.19B for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen Inc | 5.877B |
| Regeneron Pharmaceuticals Inc | 29.35B |
| Vertex Pharmaceuticals Inc | 16.41B |
| Viking Therapeutics Inc | 880.28M |
| Moderna Inc | 10.90B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 78.71B |
| Total Liabilities (Quarterly) | 64.44B |
| Debt to Equity Ratio | 2.371 |
| Current Ratio | 1.154 |
| Net Debt Paydown Yield | -0.39% |